Pharmacopuncture for Acute peripheral facial paralysis: A systematic review and meta-analysis of randomized controlled trials

⋅Received:16 February 2015 ⋅Revised:16 June 2015 ⋅Accepted:22 June 2015 ⋅Correspondence to:Su Hee Jang Department of Acupuncture & Moxibustion, Nasaret Korean Medical Hospital, Incheon, Republic of Korea Inchoen Namdonggu Gansuk 2dong 207-1 Tel:+82-32-435-5111, Fax:+82-32-435-5115, E-mail:[email protected] Objectives: This study aims to evaluate the efficacy of pharmacopuncture in the treatment of acute peripheral facial paralysis (APFP) through a meta-analysis of randomized controlled trials to assess the clinical evidence for pharmacopuncture as a treatment for PFP. Methods: Literature was searched using databases. The search terms used were “pharmacopuncture,” “sweet BV,” “apipuncture,” “apitoxin,” “injection acupuncture,” and “herbal acupuncture” in English and “bongchim,” “bongyakchim,” and “yakchim” in Korean. The RevMan 5.2 program was used for meta-analysis. Results: In all, 1902 studies were screened and the full texts of 219 articles were reviewed. Of these, nine studies were included in the systematic review and nine studies were included in the meta-analysis. Treatments utilizing bee venom, sweet bee venom (SBV), Soyeom, Calculus Bovis · Fel Ursi · Moschus (BUM), Hominis Placenta, and Suseunghwagang (SSHG) were observed in nine RCTs. In the forest plot, the diamond favors the PA treatment against the control treatment. (95% CI: 0.34 [0.08, 0.60], Z = 2.57, P = 0.01), which Our meta-analysis in RevMan 5.2 confirmed the significant efficacy of PA in treating APFP. Conclusion: Our systematic review and meta-analysis suggest that treatments using Soyeom, bee venom, and BUM are effective in APFP and they reduce the duration of postauricular pain occurring at the acute stage of APFP. However, due to small effect size, further investigation is needed.